Phase 1 Trial of Interleukin 12 Gene Therapy for Locally Recurrent Prostate Cancer
Condition(s):Prostate CancerLast Updated:March 3, 2022Unknown status
Hide Studies Not Open or Pending
Condition(s):Prostate CancerLast Updated:March 3, 2022Unknown status
Condition(s):Esophagus CancerLast Updated:March 12, 2024Recruiting
Condition(s):Hypopharyngeal Neoplasm Malignant PrimaryLast Updated:November 10, 2020Not yet recruiting
Condition(s):Head and Neck CancerLast Updated:May 4, 2006Completed
Condition(s):Esophageal Squamous Cell Carcinoma; Chemoradiotherapy; SurvivalLast Updated:November 2, 2021Recruiting
Condition(s):Nasopharyngeal Carcinoma; Neoadjuvant ChemotherapyLast Updated:May 12, 2020Unknown status
Condition(s):Head and Neck Squamous Cell CarcinomaLast Updated:February 20, 2024Recruiting
Condition(s):Prostatic Neoplasms; Pelvic NodalLast Updated:October 12, 2021Terminated
Condition(s):Cardiac Toxicity; Lung Cancer Stage III; Lung Cancer Stage II; Radiation Toxicity; Cardiac DiseaseLast Updated:December 6, 2023Recruiting
Condition(s):ChordomaLast Updated:October 23, 2019Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.